{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:57:12Z","timestamp":1785938232664,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1124\/jpet.118.250902","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T14:25:24Z","timestamp":1535379924000},"page":"222-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interactions between Cocaine and the Putative Allosteric Dopamine Transporter Ligand SRI-31142"],"prefix":"10.1016","volume":"367","author":[{"given":"Megan J.","family":"Moerke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Ananthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Eltit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelen C.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra K.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler W.E.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.250902_bib1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/acschemneuro.8b00138","article-title":"Effects of N-alkyl-4-methylamphetamine optical isomers on plasma membrane monoamine transporters and abuse-related behavior","volume":"9","author":"Battisti","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.118.250902_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1476-5381.2012.02214.x","article-title":"Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats","volume":"168","author":"Bauer","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.250902_bib3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00213-013-3405-1","article-title":"The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats","volume":"231","author":"Bauer","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.250902_bib4","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0022-3565(25)24002-2","article-title":"GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat","volume":"271","author":"Baumann","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.250902_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1124\/jpet.118.250902_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-013-3223-5","article-title":"Abuse-related and abuse-limiting effects of methcathinone and the synthetic \u201cbath salts\u201d cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats","volume":"231","author":"Bonano","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.250902_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2014.09.006","article-title":"Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats","volume":"743","author":"Bonano","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.250902_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ceca.2015.06.013","article-title":"Amphetamine activates calcium channels through dopamine transporter-mediated depolarization","volume":"58","author":"Cameron","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1124\/jpet.118.250902_bib9","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/nprot.2007.441","article-title":"Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation","volume":"2","author":"Carlezon","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1124\/jpet.118.250902_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1124\/jpet.300.3.831","article-title":"Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys","volume":"300","author":"Czoty","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.250902_bib11","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.250902_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1037\/1064-1297.3.3.232","article-title":"Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II. Comparisons with other drugs and repeated administrations","volume":"3","author":"Glowa","year":"1995","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.118.250902_bib14","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41386-018-0071-3","article-title":"Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats","volume":"43","author":"Johnson","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.118.250902_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2014.07.016","article-title":"Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1\/2-dependent mechanism","volume":"86","author":"Kivell","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.118.250902_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/FBP.0000000000000288","article-title":"Oral modafinil facilitates intracranial self-stimulation in rats: comparison with methylphenidate","volume":"28","author":"Lazenka","year":"2017","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.118.250902_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/jpet.103.060293","article-title":"Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging","volume":"309","author":"Lindsey","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.250902_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(94)90559-2","article-title":"U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats","volume":"181","author":"Maisonneuve","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.118.250902_bib19","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1021\/jm960305h","article-title":"Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)","volume":"39","author":"Matecka","year":"1996","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.118.250902_bib20","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/npp.2014.322","article-title":"Agonist medications for the treatment of cocaine use disorder","volume":"40","author":"Negus","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.118.250902_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pbb.2008.08.002","article-title":"Effects of the monoamine uptake inhibitors RTI-112 and RTI-113 on cocaine- and food-maintained responding in rhesus monkeys","volume":"91","author":"Negus","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.118.250902_bib22","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/pr.112.007419","article-title":"Intracranial self-stimulation to evaluate abuse potential of drugs","volume":"66","author":"Negus","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.118.250902_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1124\/jpet.108.139675","article-title":"Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release","volume":"326","author":"Pariser","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.250902_bib24","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1124\/jpet.118.250902_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.118.250902_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpain.2012.11.006","article-title":"Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats","volume":"14","author":"Rosenberg","year":"2013","journal-title":"J Pain"},{"key":"10.1124\/jpet.118.250902_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.114.222299","article-title":"Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency","volume":"353","author":"Rothman","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.250902_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1369.064","article-title":"Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs","volume":"1074","author":"Rothman","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.118.250902_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcp.2007.08.007","article-title":"Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction","volume":"75","author":"Rothman","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.118.250902_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ceca.2014.04.003","article-title":"Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels","volume":"56","author":"Ruchala","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1124\/jpet.118.250902_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1037\/pha0000183","article-title":"Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats","volume":"26","author":"Sakloth","year":"2018","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.118.250902_bib33","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","article-title":"Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats","volume":"233","author":"Schindler","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.250902_bib34","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/npp.2017.98","article-title":"N-alkylated analogs of 4-methylamphetamine (4-MA) differentially affect monoamine transporters and abuse liability","volume":"42","author":"Solis","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.118.250902_bib35","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1074\/jbc.M111.267757","article-title":"4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP+) is a fluorescent substrate for the human serotonin transporter","volume":"287","author":"Solis","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.118.250902_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.115.229559","article-title":"Abuse-related neurochemical effects of para-substituted methcathinone analogs in rats: microdialysis studies of nucleus accumbens dopamine and serotonin","volume":"356","author":"Suyama","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.250902_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)57007-4","article-title":"Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors","volume":"57","author":"Tanda","year":"2009","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.118.250902_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(24)29312-5","article-title":"Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans","volume":"299","author":"Walsh","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.250902_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","article-title":"Addictive drugs and brain stimulation reward","volume":"19","author":"Wise","year":"1996","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/jpet.118.250902_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00213-017-4739-x","article-title":"Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats","volume":"235","author":"Zanettini","year":"2018","journal-title":"Psychopharmacology (Berl)"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.250902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:02:16Z","timestamp":1739995336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524267197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0022356524267197"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.250902","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between Cocaine and the Putative Allosteric Dopamine Transporter Ligand SRI-31142","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.250902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}